Cerebral Oxygen Saturation Measurement During Cardioversion Because of Atrial Fibrillation
Electrical Cardioversion of Atrial Fibrillation, Pharmacological Cardioversion of Atrial Fibrillation
About this trial
This is an interventional supportive care trial for Electrical Cardioversion of Atrial Fibrillation focused on measuring cardioversion, atrial fibrillation
Eligibility Criteria
Inclusion Criteria:
- older than 18 years and able to give informed consent
- diagnosis of paroxysmal or persistent atrial fibrillation
- scheduled for electrical cardioversion or atrial fibrillation development in the first days after cardiac surgery followed by pharmacological treatment with amiodarone
- Dutch speaking
Exclusion Criteria:
- younger than 18 years or not able to give informed consent
- diagnosis of permanent atrial fibrillation
- atrial fibrillation with thrombus in left atrial appendage
- chronic obstructive pulmonary disease GOLD class 3 or 4
- airway manipulation during cardioversion
- pregnant women
- medical history of cerebrovascular accident or brain injury
- medical history of cardiopulmonary resuscitation
Sites / Locations
- Ziekenhuis Oost-Limburg
Arms of the Study
Arm 1
Arm 2
Other
Other
electrical cardioversion
pharmacological cardioversion
Hemodynamic unstable patients with atrial fibrillation who are scheduled to undergo electrical reconversion to convert their irregular heart rhythm into a normal sinus rhythm. Cerebral tissue oxygen saturation is measured by means of SenSmart Model X-100, Nonin Medical.
Patients who develop atrial fibrillation after cardiac surgery. Pharmacological treatment with amiodarone is started in order to convert their irregular heart rhythm into a normal sinus rhythm. Cerebral tissue oxygen saturation is measured by means of SenSmart Model X-100, Nonin Medical.